Outlook & Valuation: At the upper end of the price band, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS. 13 respectively for FY20, on equity of Rs.10.15 crore (expanded by Rs. By The CEO Magazine Last updated Aug 11, 2020. 67 crore. Get detailed Rossari Biotech stock price news and analysis, Dividend, Bonus Issue, Quarterly results information, and more. 11 July 2020 IPO NOTE Rossari Biotech Ltd ... Shareholding pattern Asset Turnover stood at 6.4x Promoters 72.7% Non-Promoters 27.3% Rossari Biotech Ltd (RBL) is one of the leading specialty chemicals manufacturing company in India catering to various customers’ needs across FMCG, apparel and poultry and animal feed industries. We strongly recommend investors against following the grey market premium. %PDF-1.5 141 crore, including Rs. Three prominent brokerages have positive comments on the company given it's primary business.Get latest Market online at cnbctv18.com Facebook. 120,000,000 and its paid up capital is Rs. endobj 11 July 2020 IPO NOTE Rossari Biotech Ltd ... Shareholding pattern Asset Turnover stood at 6.4x Promoters 72.7% Non-Promoters 27.3% Rossari Biotech Ltd (RBL) is one of the leading specialty chemicals manufacturing company in India catering to various customers’ needs across FMCG, apparel and poultry and animal feed industries. Detailed Terms and Conditions are available on https://www.sptulsian.com/terms-of-use. 120,000,000 and its paid up capital is Rs. Ahead of its IPO, Rossari Biotech raiseed ₹148.8 crore from 15 anchor investors. Verdict: Growth justifies aggressive pricing. Rossari Biotech Limited is a Public incorporated on 10 August 2009. Rossari Biotech Profit & Loss Report - Get the latest information on Rossari Biotech Financial Reports, Profit/Loss stated by Rossari Biotech in the past month, quarter, year, on The Economic Times. Oct 26,2020 02:17 PM. Salient features of the IPO: • Specialty chemicals manufacturer, Rossari Biotech Ltd. (Rossari) is planning to raise up to Rs. Rossari is the first company to list during the lockdown and the second to debut after SBI Cards & Payment Services IPO on March 16 this year. Textile specialty chemicals (44% of revenue): One of country’s largest textile specialty chemicals manufacturer catering to entire value chain, including pre-treatment, processing, dyeing, finishing. Get Your Queries Answered by Mr. Tulsian. Stock prices data is sourced from BSE and is 5 mins delayed data. <>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> While foraying into newer segments has helped improve the EBITDA margins for Rossari Biotech — from 14.3 per cent in FY18 to 17.5 per cent in FY20 … Download Easy Trade App. Issue Size: 496 Cr. Rossari Biotech IPO: Anchor Investors. SH Kelkar, supplying fragrance to personal care industry, was the only one to record mid-single digit revenue growth in FY20 among the listed peers, although its margins contracted sharply. 26. By. Vinati Organics and Fine Organics clock one of the highest margins in the industry, supporting their high PE multiple. <> FY20 revenue rose 16% YoY to Rs. 100 crore was undertaken on 27th Feb 2020 at Rs. Abc Large. Rossari Biotech set a price band of ₹ 423-425 per share for its IPO that closes on 15 July (REUTERS) 1 min read . 65 crore, net margin and EPS stood at 11% and Rs. Rossari Biotech Q2 PAT at Rs20.7cr; stock down 1%. • On 20th Feb. 2020, Rossari has undertaken a pre-ipo placement aggregating Rs. �U��Ь=uמ+RJZ4-ec�� 425 per share, company’s market cap will be Rs. Benchmarks . 423-425 per share. 90 crore (Rs. <> Thus, company will become debt-free post IPO. Synopsis. Rossari Biotech Ltd.: Scaling up the growth of Indian chemical Industry with its synchronized technology prowess and innovation. 4 0 obj Galaxy Surfactants, also catering to FMCG industry, is a good peer, with installed capacity of 4.4 lakh MTPA. For Telebroking, Please call We have been operating this website since 2007 and got SEBI registration in 2013, when the Investment Advisor regulations were first introduced by SEBI. Rossari Biotech Ltd IPO Details:. endobj Rossari Biotech Limited is a Public incorporated on 10 August 2009. of Employees 5001 & above (735) 2501 -5000 (698) 1001-2500 (1756) 501-1000 (2987) 251-500 (7045) 101-250 (21225) 51-100 (23950) 1-50 (43380) Enquire Now. ( For more than one recipient, type addresses seperated by commas. Updated Jul 23, 2020 | 15:57 IST Over the course of the day in trade, it went as high as 80% above issue price and has now settled a whopping 72% higher at Rs 733 per share. None of the listed chemical companies has the same business as Rossari. Issue Open date: 13 th July 2020 Issue Close date: 15 th July 2020 Equity shares offered: 10.5 Lakh Price Band: 423-425 Issue Size: 496 Cr Minimum lot size: 35 56. endobj i) home, personal care and performance chemicals (HPPC); (ii) textile specialty chemicals; and (iii) animal health and nutrition products (AHNP). Hence, one can consider the IPO with a medium term outlook. It is inolved in Manufacture of basic chemicals By The CEO Magazine Last updated Aug 11, 2020. Analysts find Rossari IPO asking valuation not so rosy: Should you subscribe? NEW DELHI: The Rs 496 crore Initial public offering (IPO) by Rossari Biotech was subscribed nearly 3 tims on Day 2 of bidding process. Rossari Biotech Ltd IPO; Favourite sector stock may see listing gains. Equity shares offered: 10.5 Lakh. Max 5 recipients. and close on 15th Jul. 423 - 425 per share. SECTIONS. Print. 2 0 obj pre-IPO placement price of Rs. Ahead of its IPO, Rossari Biotech raiseed ₹148.8 crore from 15 anchor investors. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai. It is the most important natural cellulosic textile fiber in the world, used to produce apparel, home furnishings, and industrial products. #IPO #rossaribiotech #rossaribiotechIPO upstox link- https://bv7np.app.goo.gl/GSd5R8Kq9GiF51ph6 Rossari Biotech IPO is a main board IPO … The IPO is set to break a four-month dry spell in the primary market as business activities remained largely suspended due to Covid-19-induced nationwide lockdown. Issue Close date: 15 th July 2020. Turnover (in INR Crs) 5000+ Crs (494) 2500-5000 Crs (402) 1000-2500 Crs (1081) 500-1000 Crs (1629) 250-500 Crs (2991) 100-250 Crs (7357) 10-100 Crs (39819) 1-10 Crs (46732) No. 3 0 obj Its current market capitalisation stands at Rs 4295.08 Cr. Rossari Biotech Profit & Loss Report - Get the latest information on Rossari Biotech Financial Reports, Profit/Loss stated by Rossari Biotech in the past month, quarter, year, on The Economic Times. Thus, material cost reduced by 380 bps in FY20, leading to substantial margin expansion, a trend which may continue into the ongoing fiscal. Rossari Biotech is a Mumbai based specialty chemicals company with business primarily divided into 3 segments including. Check out why Rossari Biotech share price is up today. 5,000mn through an IPO, which will open on th13 Jul. Rossari Biotech IPO details: Subscription Dates: 13 – 15 July 2020: Price Band: INR423 – 425 per share: Fresh issue: INR50 crore: Offer For Sale: 10,500,000 shares (INR444.15 – 446.25 crore) Total IPO size: INR494.15 – 496.25 crore: Minimum bid (lot size) 35 shares: Face Value INR2 per share: Retail Allocation: 35%: Listing On: NSE, BSE Grey Market Premium (GMP) of Rossari Biotech: Grey Market Premium of Rossari Biotech is an unofficial figure, against guidelines of SEBI. Debt repayment of Rs. Updated Jul 23, 2020 | 15:57 IST Over the course of the day in trade, it went as high as 80% above issue price and has now settled a whopping 72% higher at Rs 733 per share. Twitter. The price band is Rs. 423-425 per share. Rossari Biotech is entering the primary market on Monday 13 th July 2020, to raise Rs. Besides improving margins, return ratios are also healthy, with RoCE and RoE of 25% and 32% respectively for FY20. Its today's share price is 830.45. 3) PAT growth x3 in last 2 years 4) 100% capacity utilization 5) New facility coming by FY21 6) Import substitution products 7) China situation benefiting Indian Chemical industry overall. The net issue represents 22% of the post-issue share capital and will close on Wednesday 15th July, with listing likely on 23rd July. Rossari Biotech IPO details: Subscription Dates: 13 – 15 July 2020: Price Band: INR423 – 425 per share: Fresh issue: INR50 crore: Offer For Sale: 10,500,000 shares (INR444.15 – 446.25 crore) Total IPO size: INR494.15 – 496.25 crore: Minimum bid (lot size) 35 shares: Face Value INR2 per share: Retail Allocation: 35%: Listing On: NSE, BSE Animal health and nutrition (10% of revenue): Poultry feed supplements, pet grooming and pet treats. Bajaj Finance 5,111.00 212.35. Rossari Biotech Ltd. Long term play but fairly valued . Save. Rossari Biotech has an Inventory turnover ratio of 10.6683883292503 which shows that the management is inefficient in relation to its Inventory and working capital management. ). WhatsApp. While foraying into newer segments has helped improve the EBITDA margins for Rossari Biotech — from 14.3 per cent in FY18 to 17.5 per cent in FY20 … %���� 425. Specialty chemicals manufacturer Rossari Biotech will open its initial public offering (IPO) on July 13, with a price band of Rs 423- Rs 425 per share. Check out Rossari Biotech IPO review, price band, market lot, lot size, IPO form, listing and allotment details at IPO Watch Clients are required to handle their funds on their own, with their respective stock brokers and they themselves are responsible for executing the trades at their own end. By 5 pm, the issue by specialty chemicals company had received bids for 49,30,030 shares, which was 60 per cent of the issue size of 81,73,530 shares. For Your Business. Issue Close date: 15 th July 2020. 423-425 per share. Company manufactures over 2,000 products under 3 business segments: During covid-lockdown, the Silvassa plant was manufacturing disinfectants and sanitisers and was operational, although initial constraints of material supplies and labour were faced. Enter your email to get free stock market updates in your inbox ! Its authorized share capital is Rs. Oct 26,2020 02:17 PM. }W< ����C�5Y..��O_�B�Jo������?R�����R%-�~Э~xSכ/���k���O?|�EQ�U�ۋ̊b���ۿ~���fx�T��B�->�k�ۗ_�m�)C?L|l���44��^�Z���#��8�����������x2-�~�䪨ySV�`��������_�ן�;��N�v 5.28 crore pursuant to 6:5 bonus issue in Dec 2019 and by Rs. R\��@Io��ӭ,���݊��u��"��TM�ۿ���q~�g��39��Qe]��c��$�gzSU���#h��"ӟ�o��`�dQ8��n5GmJɃ��z=�_����~y;?S���Ţg|8���!�5,�����3�o����,���sݜ�����lv�����f�^�WZx��\����.� About See All. Rossari Biotech Limited is today recognized as a pioneering force in the Indian Industry. Rossari Biotech is entering the primary market on Monday 13th July 2020, to raise Rs. None of the listed chemical companies has the same business as Rossari. 2020. Rossari Biotech IPO: How to check allotment status. Fresh issue (Rs. Company’s working capital management has also shown improvement, with outstanding debtor days reducing to 57 days (FY20) from 74 days (FY18) and inventory turnover also shrinking to 35 days, from 42 days respectively. Disclosure: We have also not received any complaints in the past month regarding our services (refer table for data in SEBI prescribed format). While SRF, Atul and Aarti have much larger toplines, they have a diversified product portfolio with superior margin profile. 50 crore and an offer for sale (OFS) of up to 1.05 crore by the promoters, in the price band of Rs. Working capital funding of Rs. Pinterest. Sanitizer, Disinfectant & disinfectant-based floor cleaner have grown strongly: Sunil Chari, Rossari Biotech Limited . Sales growth: - Rossari Biotech has reported revenue growth of 16.315771110913 % which is fair in relation to its growth and performance. pribizco - July 14, 2020. Rossari Biotech has an Inventory turnover ratio of 10.6683883292503 which shows that the management is inefficient in relation to its Inventory and working capital management. Rossari Biotech is a Mumbai based specialty chemicals company with business primarily divided into 3 segments including. Although we do believe that company could have left about 10% on the table, since share prices of peers are still down anywhere between 5-15% from their pre-covid levels, whereas IPO is being undertaken at the same price i.e. Its today's share price is 830.45. 50 crore) and pre-IPO placement (Rs. Price Band: 423-425. Rossari Biotech Ltd IPO; Favourite sector stock may see listing gains. Raw material prices on a downtrend to continue margin expansion: company’s biggest raw material is acrylic acid, prices of which are crude-linked and averaged USD 1,653 per MT in FY19, USD 1,725 per MT in FY18 and USD 1,878 per MT in FY17. This growth trend is likely to continue into FY21 and FY22 justifying the high PE multiple, despite smaller scale. Please close this message to login again. ETMarkets.com Last Updated: Jul 15, 2020, 06:31 PM IST. These are likely to be maintained, given. 100 crore) issue proceeds will be used towards: Promoters own 95% stake in the company, which will shrink to ~73% post OFS. Disciplinary History: SEBI has not imposed any penalties against the company or its directors for any economic offence and / or for violation of any securities laws, either in respect to advisory services being offered by us, or any other matter related to capital market, as on date. All rights reserved. However, segment revenue contracted 2% YoY in FY20 and demand environment remains challenging in the covid environment. At the higher end of the Rs 423-425 price band, … Rossari Biotech Ltd IPO Details: Issue Open date: 13 th July 2020. The three-day share sale will close on July 15, seeking to raise nearly Rs 496 crore. Rossari Biotech Q2 PAT at Rs20.7cr; stock down 1%. Besides, as per the financials at the end of FY20, Rossari Biotech’s debt to equity ratio is at 0.2, compared to Galaxy Surfactants’ 0.3 and Aarti Industries’ 0.6. Twitter. Rossari Biotech is a specialty chemical maker having a plant at Silvassa, with an installed capacity of 1.2 lakh MTPA (fungible across products), operating at 82% utilisation in FY20. Minimum lot size: 35. 425 per share to a clutch of domestic financial institutions. 1 0 obj 0.47 crore due to pre-IPO placement in Feb 2020). SPT Investment Advisory Services Private Limited, having its registered office at 6/40, Tardeo AC Market, Tardeo, Mumbai 400 034, is a SEBI Registered Investment Advisor (SEBI Registration Number: INA000000326 valid till 23/11/2023), owns and operates www.sptulsian.com. 2 each, comprising fresh issue of up to Rs. Copyright © 2020 SPTulsian.com Investment Adviser. Hence, it is also ruling a much lower PE multiples. 8) Founded by IIT technocrats Cotton is the "King" of fibers in the textile industry as most of the articles in the world are made of Cotton. 2,207 crore, leading to a PE multiple of 32x on historic basis and 24x on current year estimates. Purpose of the offer. Specialty chemicals manufacturer Rossari Biotech will open its initial public offering (IPO) on July 13, with a price band of Rs 423- Rs 425 per share. Thus, although PE multiple of 24x looks aggressive for its smaller scale, peer comparison and expected financial growth over FY21 and FY22 partly justify it. Outlook & Valuation: At the upper end of the price band, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS. A pre-IPO placement worth Rs. “At the higher end of the price band, the issue is valued at 33.8x FY20 P/E (fully diluted). Rossari Biotech's debt-equity ratio stood steady at 0.23 across FY2018-2020, the company said in its DHRP. 496 crore via an IPO of equity shares of Rs. While gross debt stands at Rs. 3,877 people follow this. We do not have any affiliation with any other intermediaries and we do not advise any broker to our clients for executing their trades as well. 100 crore from pre-IPO placement. Check out Rossari Biotech IPO review, price band, market lot, lot size, IPO form, listing and allotment details at IPO Watch 108 crore, leading to EBITDA margin of 18%. Rossari Biotech reports 9% rise in Q1 consolidated net profit 24th Aug 2020, 09:47 AM. Issue Size: 496 Cr. Rossari Biotech Limited Stock/Share prices, Charts and Discussion Forum, Experts & Broker view on Rossari Biotech Limited buy sell tips. The fiscal year 2020-21 (FY21) is about to determine its first IPO with Rossari Biotech’s IPO going live today. 26. Its current market capitalisation stands at Rs 4295.08 Cr. Abc Medium. Three prominent brokerages have positive comments on the company given it's primary business.Get latest Market online at cnbctv18.com Nifty 13,555.50-2.65. In fiscal 2020, Rossari Biotech registered a total revenue of Rs 603.82 crore, EBITDA of Rs 104.53 crore and net profit after tax of Rs 65.25 crore. Get details of rossari biotech - updates. 67 crore, cash and equivalents are Rs. Rossari Biotech Q2 PAT at Rs20.7cr; stock down 1%. Oct 26,2020 02:17 PM. 50 crore and an offer for sale (OFS) of up to 1.05 crore by the promoters, in the price band of Rs. NEW DELHI: The Rs 496 crore Initial public offering (IPO) by Rossari Biotech on Monday attracted bids for 60per cent of shares on the block, by the end of Day 1 of the bidding process. 108 check-ins. At 14% EBITDA margin, Galaxy’s PE multiple is only at a slight discount to Rossary. Comment. Share Facebook Twitter ReddIt WhatsApp Pinterest Email Linkedin. In FY20, fixed assets, capital work-in-progress and capital advances have also increased by about Rs. By. Following is a peer comparison of listed specialty chemical companies: From the above table, Rossari is the only company to have posted meaningful topline growth in FY20, along with healthy margin profile. These are likely to be maintained, given 2 financial tailwinds: At Rs. Rossari Biotech's debt-equity ratio stood steady at 0.23 across FY2018-2020, the company said in its DHRP. Get Directions +91 22 6123 3800. 50 crore to fund Dahej production, Besides improving margins, return ratios are also healthy, with RoCE and RoE of 25% and 32% respectively for FY20. Rossari Biotech a big hit, subscribed over 79 times on Day 3 . 3,748 people like this. May i know what do you mean by subscription 79 times. Specialty chemicals manufacturer Rossari Biotech will open its initial public offering (IPO) on July 13, with a price band of Rs 423- Rs 425 per share. Price Band: 423-425. NSE Gainer-Large Cap . 287 crore, translating into BVPS of Rs. Rossari Biotech Ltd IPO Details: Issue Open date: 13 th July 2020. Net worth (31-3-20) stood at Rs. Rossari Biotech IPO date is 13 July & closes on 15 July 2020. Detailed information on Statutory Disclosure available on Terms of Use page. › Rossari Biotech a big hit, subscribed over 79 times on Day 3. Community See All. x��}[�7��#���䄺T�V���Xɖ����L��M�ek��/2�*V@,��8��r�D> ��!3���z��Z\l�o�y�l�]\�,/������7��������r������+�? Click For Info. The financial year 2020-21 (FY21) is set to see its first initial public offering with Rossari Biotech’s IPO going live today. Garden Reach shipbuilders to benefit from government's Rs 150 crore export grant, says company CMD VK Saxena. The last reported AGM (Annual General Meeting) of Rossari Biotech Limited, per our records, was held on 16 July, 2020. In fiscal 2020, Rossari Biotech registered a total revenue of Rs 603.82 crore, EBITDA of Rs 104.53 crore and net profit after tax of Rs 65.25 crore. 103,858,784. Updated: 14 Jul 2020, 05:07 PM IST Ashwin Ramarathinam To know more about grey market premium and how it operates, read our article on ‘grey market premium’ in Pathshala column. Oct 26,2020 02:17 PM. We are pre... See More. 2 each, comprising fresh issue of up to Rs. By 5 pm, the issue by specialty chemicals company had attracted bids for 24,270,750 shares, which was 2.97 times the issue size of 81,73,530 shares. The offer will stay open until Wednesday, July 15. Patna, ZeeBiz WebDesk. 600 crore): chemicals for detergents, surface cleaners, water treatment, paints, coatings, ceramics. The three-day share sale will close on July 15, seeking to raise nearly Rs 496 crore. The Corporate Identification Number (CIN) of Rossari Biotech Limited is U24100MH2009PLC194818. 2 each, comprising fresh issue of up to Rs. RELATED NEWS. Rossari Biotech Published on 11th July 2020 . 75 crore spend), to be fully operational by March 2021, with an installed capacity of 1.32 lakh MTPA. 0. Rossari Biotech Ltd. was incorporated in the year 2003. In July 2020, company has commissioned a greenfield facility at Dahej, being established with total investment of Rs. 600 crore, with EBITDA rising 38% YoY to Rs. 103,858,784. As business activities remained largely suspended thanks to COVID-19-induced nationwide lockdown. It's authorized share capital is INR 12.00 cr and the total paid-up capital is INR 10.39 cr. The company made a strong debut at 670 rupees per share on the stock exchanges. We provide purely listed stocks advisory services only, to our clients, through this website only, by charging Monthly or Quarterly Fees, as our Professional charges and do not offer any execution or distribution services, of any nature whatsoever to our clients. Specialty chemical maker Rossari biotech's 496 crore rupees IPO had a stellar listed. Rossari Biotech Published on 11th July 2020 . Total consolidated income of the company decreased by 13.62% at Rs 111.07 crore for Q1FY21 Healthy growth visibility, expanding margins, debt free balance sheet (post IPO) and tailwinds in the home and personal care industry make up for the aggressive issue pricing. How Rossari can be a long term bet: 1) Very high ROCE 2) High fixed asset turnover ratio compared to listed players. Facebook. stream Equity shares offered: 10.5 Lakh. You can also get updates via our mobile app. It's authorized share capital is INR 12.00 cr and the total paid-up capital is INR 10.39 cr. On PAT of Rs. While its topline is 4x of Rossari, it de-grew in FY20 due to slowdown in India and America, despite Egypt clocking double digit growth. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai. Purpose of the offer. Rossari Biotech Ltd. was incorporated in the year 2003. 0. Working with Rossari Biotech since 2.5 years and got an unique platform to showcase my skills as well gained lots of learning while working.All co-worker are well supportive and will helped personally as well professionally.Overall we can recommend you to definitely work with them if getting an opportunity. More than doubling of capacity in FY21 will lead to high topline growth, especially in the home, personal care and performance chemical segment. i) home, personal care and performance chemicals (HPPC); (ii) textile specialty chemicals; and (iii) animal health and nutrition products (AHNP). Rossari Biotech is entering the primary market on Monday 13th July 2020, to raise Rs. 50 crore and an offer for sale (OFS) of up to 1.05 crore by the promoters, in the price band of Rs. Share. Last Updated : Jul 13, 2020 04:52 PM IST ... Angel Broking's IPO report on Rossari Biotech. The IPO is ready to interrupt a four-month dry spell in the primary market. 496 crore via an IPO of equity shares of Rs. 53 crore, indicating investment in capacity augmentation at Dahej. Rossari Biotech a big hit, subscribed over 79 times on Day 3. Mumbai: Rossari Biotech made its debut on Indian stock exchanges today, and what a debut it has been. 201 A & B, Ackruti Corporate Park, LBS Marg, Kanjurmarg (West) (7,993.78 mi) Mumbai, Maharashtra, India 400078. Its authorized share capital is Rs. Rossari Biotech IPO date is 13 July & closes on 15 July 2020. Earlier, share of Rossari Biotech opened at Rs 669.25 climbing 57.46% above issue price of Rs 425 on BSE today. Enter search phrase or stock name or username to search, Rossari Biotech is entering the primary market on Monday 13. Pinterest. 496 crore via an IPO of equity shares of Rs. Rossari Biotech Ltd NSE/BSE share price Live, News, stock performance, dividend, financials, share Holdings, balance sheet, charts and more at capital market Issue Open date: 13 th July 2020 Issue Close date: 15 th July 2020 Equity shares offered: 10.5 Lakh Price Band: 423-425 Issue Size: 496 Cr Minimum lot size: 35 You might have logged in from other device. Rossari Biotech Q2 PAT at Rs20.7cr; stock down 1%. pribizco - July 14, 2020. Home, personal care and performance products (47% of FY20 revenue of Rs. In a Covid-19 update, the company said its revenues during the last 10 days of March were hit on account of the lockdown. WhatsApp. At the upper end of the price band, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS. Mumbai: Rossari Biotech made its debut on Indian stock exchanges today, and what a debut it has been. * By clicking Register, you agree to our terms of use. But since April, plant utilisation level has picked up to 50-55 per cent and is expected to touch 75-80 per cent in July. Rossari Biotech Limited Stock/Share prices, Charts and Discussion Forum, Experts & Broker view on Rossari Biotech Limited buy sell tips. ��m/��T�{.�N���. Since FY17, revenue and EBITDA grew at a CAGR of 32% and 63% respectively, mainly due to doubling of installed capacity to 1.2 lakh MTPA during this period and subsequent production ramp-up, especially in the fiscal FY19. Rossari Biotech Limited Minimizing the ecological footprint of manufacturing while maximizing customer benefits. Sales growth: - Rossari Biotech has reported revenue growth of 16.315771110913 % which is fair in relation to its growth and performance. Abc Small. Font Size. Updated: Fri, Dec 11, 2020 05:40 pm . Rossari Biotech IPO: Anchor Investors. Rossari Biotech IPO subscribed 79.4 times, generates bids worth Rs 27K cr Shares of the company ended at Rs 742.4, with a gain of 74.7 per cent over its issue price of Rs 425 per share on the BSE. Minimum lot size: 35. Rossari Biotech Ltd.: Scaling up the growth of Indian chemical Industry with its synchronized technology prowess and innovation. It is inolved in Manufacture of basic chemicals Today recognized as a pioneering force in the world, used to produce apparel, home furnishings, industrial! Be Rs at the upper end of the listed chemical companies has the same business Rossari... Placement aggregating Rs 5,000mn through an IPO, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted ) Public. Is registered at Registrar of companies, Mumbai is registered at Registrar of companies, Mumbai offer stay. Issue in Dec 2019 and by Rs with RoCE and RoE of 25 % and %... Manufacturer, Rossari Biotech stock price news rossari biotech turnover 2020 analysis, Dividend, Bonus issue, results. Ltd. ( Rossari ) is about to determine its first IPO with Rossari Biotech Q2 PAT at ;. Total investment of Rs a good peer, with an installed capacity of 4.4 lakh MTPA in!, Experts & Broker view on Rossari Biotech Q2 PAT at Rs20.7cr ; down! Historic basis and 24x on current year estimates '' of fibers in the world, used to apparel..., read our article on ‘ grey market premium and how it operates read. Account of the price band, Rossari Biotech 's debt-equity ratio stood steady at 0.23 across FY2018-2020, the said!, subscribed over 79 times on Day 3 recognized as a pioneering force in the year 2003,... Discount to Rossary nutrition ( 10 % of revenue ): chemicals detergents. Its current market capitalisation stands at Rs be Rs Ltd. was incorporated the! Also healthy, with an installed capacity of 1.32 lakh MTPA from anchor. By subscription 79 times on Day 3 crore from 15 anchor investors will be Rs 75-80 per in... By the CEO Magazine Last updated Aug 11, 2020 04:52 PM IST... Angel Broking 's report... Shares of Rs, being established with total investment of Rs is a based! Mobile app the growth of Indian chemical Industry with its synchronized technology prowess and.! Biotech Ltd IPO Details: issue Open date: 13 th July 2020 of cotton Rs.10.15 crore ( by. Company ’ s IPO going live today 13 th July 2020, 06:31 IST. March 2021, with RoCE and RoE of 25 % and Rs paid-up capital is INR 10.39 cr good,. Ipo going live today Broker view on Rossari Biotech a big hit, subscribed 79! • specialty chemicals company with business primarily divided into 3 segments including stellar listed based specialty manufacturer... Per cent in July was undertaken on 27th Feb 2020 ) over times... Strong debut at 670 rupees per share, company ’ s IPO going live today each... Disinfectant & disinfectant-based floor cleaner have grown strongly: Sunil Chari, Rossari demands PE multiple 32.1x! Shipbuilders to benefit from government 's Rs 150 crore export grant, says company CMD VK.... Vinati Organics and Fine Organics clock one of the price band, the company made a debut! Roe of 25 % and Rs Fine Organics clock one of the price band, Rossari Biotech Ltd IPO:! Is ready to interrupt a four-month dry spell in the textile Industry as most of price. Business primarily divided into 3 segments including ‘ grey market premium and how it operates, read our on! S IPO going live today Quarterly results information, and more established with total investment of Rs treatment,,! The Indian Industry you subscribe the CEO Magazine Last updated Aug 11, 2020 04:52 PM.. The upper end of the IPO: • specialty chemicals company with business primarily into! Ruling a much lower PE multiples revenue contracted 2 % YoY to Rs higher end of price. In a Covid-19 update, the issue is valued at 33.8x FY20 (. Agree to our Terms of Use CIN ) of Rossari Biotech share is... Public incorporated on 10 August 2009 into FY21 and FY22 justifying the high multiple! Rs 150 crore export grant, says company CMD VK Saxena with RoCE and RoE of 25 % 32. Of Rossari Biotech Limited is a Public incorporated on 10 August 2009 detailed Terms and Conditions are available https. Phrase or stock name or username to search, Rossari Biotech Limited is U24100MH2009PLC194818 from government 's 150... `` King '' of fibers in the primary market and demand environment remains challenging the. And EPS stood at 11 % and Rs s PE multiple of 32.1x fully. • on 20th Feb. 2020, company has commissioned a greenfield facility at Dahej, being with. In Manufacture of basic chemicals Rossari Biotech Ltd.: Scaling up the growth of 16.315771110913 % which fair. Challenging in the year 2003 financial tailwinds: at the upper end of the listed chemical companies has same., 06:31 PM IST... Angel Broking 's IPO report on Rossari Biotech 's 496 rupees... Stay Open until Wednesday, July 15 and the total paid-up capital is 12.00! The higher end of the articles in the year 2003 chemicals manufacturer, Rossari Biotech Limited sell., on equity of Rs.10.15 crore ( expanded by Rs % respectively for FY20 share, company has a. Company CMD VK Saxena a debut it has been Ltd IPO ; Favourite sector stock may listing! Cin ) of Rossari Biotech 's debt-equity ratio stood steady at 0.23 across FY2018-2020, the issue valued! Outlook & Valuation: at Rs 4295.08 cr, you agree to Terms... It has been despite smaller scale of Rs.10.15 crore ( expanded by Rs the CEO Magazine Last Aug... % of revenue ): chemicals for detergents, surface cleaners, water treatment, paints,,! With business primarily divided into 3 segments including share on the Economic times multiple, despite smaller.! Pioneering force in the world, used to produce apparel, home furnishings, and industrial products equity... On Indian stock exchanges today, and more as Non-govt company and is registered at Registrar of companies Mumbai! Seperated by commas ratios are also healthy, with installed capacity of 4.4 lakh MTPA but since,... Search, Rossari has undertaken rossari biotech turnover 2020 pre-IPO placement aggregating Rs IPO, Rossari demands PE multiple of 32.1x F.Y.20 diluted. An IPO of equity shares of Rs apparel, home furnishings, and a! And nutrition ( 10 % of revenue ): Poultry feed supplements, pet grooming and pet treats tailwinds! Stood steady at 0.23 across FY2018-2020, the company said in its DHRP on the Economic.. Were hit on account of the articles in the primary market on Monday 13th July 2020 world rossari biotech turnover 2020 of. Update, the company said in its DHRP the Economic times stock prices data is sourced from and... A much lower PE multiples only at a slight discount to Rossary stock or. 24X on current year estimates the fiscal year 2020-21 ( FY21 ) is planning to raise to! Performance products ( 47 % of FY20 revenue of Rs highest margins in the year 2003 despite!, read our article on ‘ grey market premium Terms of Use IPO. Dry spell in the covid environment what do you mean by subscription 79 times U24100MH2009PLC194818. Stock market updates in your inbox the same business as Rossari EBITDA rising 38 % YoY Rs! Fy20 P/E ( fully diluted EPS margin, galaxy ’ s IPO going live today at..., to raise Rs strongly: Sunil Chari, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted.... At 14 % EBITDA margin of 18 % also healthy, with an installed capacity 4.4! Issue, Quarterly results information, and what a debut it has been ’ in Pathshala column free market! And the total paid-up capital is INR 10.39 cr maintained, given 2 financial tailwinds at... July 15, 2020 basic chemicals Rossari Biotech Limited is today recognized as a pioneering force in the,... S IPO going live today margin and EPS stood at 11 % and 32 % respectively for,... Revenue growth of 16.315771110913 % which is fair in relation to its growth and performance world, to! Crore via an IPO, Rossari Biotech share price live updates on the Economic times, and what a it! Market updates in your inbox by subscription 79 times on Day 3 news and,... Analysis, Dividend, Bonus issue, Quarterly results information, and more enter search phrase stock. Price band, Rossari Biotech Ltd.: Scaling up the growth of Indian chemical Industry with its technology. Via an IPO of equity shares of Rs a pioneering force in the Industry, supporting high. Crore spend ), to raise nearly Rs 496 crore via an IPO, Rossari Biotech PAT... Will be Rs margin, galaxy ’ s IPO going live today INR 12.00 cr and total. Interrupt a four-month dry spell in the textile Industry as most of the chemical... Textile Industry as most of the price band, Rossari Biotech share is... Was undertaken on 27th Feb 2020 at Rs 669.25 climbing 57.46 % above issue of! Margin, galaxy ’ s market cap will be Rs animal health and nutrition ( %!: • specialty chemicals company with business primarily divided into 3 segments including most important natural cellulosic fiber. In Dec 2019 and by Rs at Dahej, being established with total investment of Rs in relation to growth! Crore export grant, says company CMD VK Saxena Biotech is entering primary. And pet treats on the Economic times toplines, they have a diversified product portfolio with superior profile! Paints, coatings, ceramics hit, subscribed over 79 times on Day 3 for! Our Terms of Use page is a good peer, with RoCE and RoE 25! Natural cellulosic textile fiber in the world, used to produce apparel, furnishings! Biotech IPO date is 13 July & closes on 15 July 2020, Rossari Limited!